This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
Reports
Cover Page
Statements
Condensed Consolidated Balance Sheets (unaudited)
Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)
Condensed Consolidated Statements of Operations (unaudited)
Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (unaudited)
Condensed Consolidated Statements of Cash Flows (unaudited)
Reports
Organization and Business
Certain Balance Sheet Components
Fair Value Measurements
Investments in Marketable Securities
Taxes
Revenue
Exclusive License and Option Agreement with Roche
Debt
Convertible Preferred Stock, Common Stock and Warrants
Recapitalization
Stock-Based Compensation
Net Income (Loss) Per Share Attributable to Common Stockholders
Commitment and Contingencies
Leases
Related Party Transactions
Segment and Geographic Information
Insider Trading Arrangements
Accounting Policies
Organization and Business (Policies)
Tables
Certain Balance Sheet Components (Tables)
Fair Value Measurements (Tables)
Investments in Marketable Securities (Tables)
Revenue (Tables)
Stock-Based Compensation (Tables)
Net Income (Loss) Per Share Attributable to Common Stockholders (Tables)
Commitment and Contingencies (Tables)
Leases (Tables)
Segment and Geographic Information (Tables)
Details
Organization and Business (Details)
Certain Balance Sheet Components - Narrative (Details)
Certain Balance Sheet Components - Schedule of Property, Plant and Equipment, Net (Details)
Certain Balance Sheet Components - Schedule of Accrued Compensation and Other Related Benefits (Details)
Certain Balance Sheet Components - Schedule of Intangible Assets, Net (Details)
Certain Balance Sheet Components - Schedule of Future Amortization Expense of Finite-Lived Intangible Assets (Details)
Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)
Fair Value Measurements - Narrative (Details)
Fair Value Measurements - Schedule of Significant Inputs used in the Fair Value Measurement (Details)
Fair Value Measurements - Change in Fair Value of the Exact Convertible Note (Details)
Investments in Marketable Securities - Schedule of Investments in Marketable Available-for-Sale Securities (Details)
Investments in Marketable Securities - Narrative (Details)
Taxes (Details)
Revenue - Narrative (Details)
Revenue - Schedule of Deferred Revenue (Details)
Revenue - Schedule of Revenue by Type (Details)
Exclusive License and Option Agreement with Roche (Details)
Debt (Details)
Convertible Preferred Stock, Common Stock and Warrants (Details)
Recapitalization (Details)
Stock-Based Compensation - Narrative (Details)
Stock-Based Compensation - Stock Option Activity (Details)
Stock-Based Compensation - Schedule of RSU Activity (Details)
Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)
Net Income (Loss) Per Share Attributable to Common Stockholders - Narrative (Details)
Net Income (Loss) Per Share Attributable to Common Stockholders - Schedule of Earnings, Basic and Diluted (Details)
Net Income (Loss) Per Share Attributable to Common Stockholders - Schedule of Potentially Dilutive Securities Excluded from Calculation of Earnings Per Share (Details)
Commitment and Contingencies - Narrative (Details)
Commitment and Contingencies - Other Noncancellable Unconditional Purchase Commitments (Details)
Leases - Narrative (Details)
Leases - Schedule of Lease Costs (Details)
Leases - Supplemental Lease Information (Details)
Leases - Schedule of Future Principal Contractual Obligations for Lease Commitments (Details)
Related Party Transactions (Details)
Segment and Geographic Information - Narrative (Details)
Segment and Geographic Information - Schedule of Revenue by Geographic Location (Details)
All Reports